STAT (@statnews) | teapawt

Tweets
All Posts Highlights
Sort by
Most recent Popular
Tweets & Replies
Reposts
Media
Search

Pinned Tweet

This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine. Meet the 2026 #STATWunderkinds! statnews.com/wunderkinds/

Meet the 2026 STAT Wunderkinds

Meet the 2026 STAT Wunderkinds

This year, as in past years, we've found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the

5

24

11,973

A former Eli Lilly sales rep filed a lawsuit alleging she was fired after claiming the company was inappropriately promoting its Mounjaro diabetes drug to combat weight loss. trib.al/1KW3j2N

Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug

Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug

A former Eli Lilly sales rep filed a lawsuit alleging she was fired after claiming the company was inappropriately promoting its Mounjaro diabetes drug to combat weight loss.

684

If you’re blind, Bill Ackman wants to help you see again. statnews.com/2026/11/09/bill…

Bill Ackman’s bold plan to transform brain research

Bill Ackman’s bold plan to transform brain research

Billionaire Bill Ackman as a bold plan to transform brain research, spurred by a tragic backstory.

1

1

780

In this edition of STAT Health Tech: Growing optimism around chatbots and men who avoid therapy, and highlights from the earnings season. trib.al/2aJWZ4k

Men's use of chatbots for therapy, and earnings season highlights

Men's use of chatbots for therapy, and earnings season highlights

In this edition of STAT Health Tech: Growing optimism around chatbots and men who avoid therapy, and highlights from the earnings season.

1

2

904

The FDA approved Bayer’s drug to reduce recurrence of stroke, making available the first in a novel class of medications that hold the promise of preventing blood clots more safely. statnews.com/2026/11/09/card…

FDA approves novel Bayer drug to reduce recurrence of stroke

FDA approves novel Bayer drug to reduce recurrence of stroke

Bayer's drug is the first in a novel class of medications designed to prevent blood clots without increasing risk of bleeding.

4

980

Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed. trib.al/XSmSDCc

Pharma is a 'mixed bag' when providing drug access to low- and middle-income countries, analysis...

Pharma is a 'mixed bag' when providing drug access to low- and middle-income countries, analysis...

Many large pharmaceutical companies are taking steps to improve access to their medicines in low- and middle-income countries, but progress has been mixed.

1

1,014

"The next century of biotechnology leadership is not destined to belong to any nation. It will be earned by the nation with the vision to invest, the courage to innovate, and the resolve to build the future." statnews.com/2026/11/10/chin…

BIO CEO: American biotech needs a coordinated plan to beat China — now

BIO CEO: American biotech needs a coordinated plan to beat China — now

BIO CEO: “Today’s biotech race is our generation’s Space Race.”

1,019

The Food and Drug Administration warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition and required pharma companies to inform patients and doctors of the risk. statnews.com/2026/11/09/glp-…

A close-up image of a retina with visible blood vessels. The text overlay reads: "FDA warns GLP-1 drugs carry potential risk of rare eye condition. Agency requiring pharma companies to inform patients, doctors of 'eye stroke' condition.

ALT A close-up image of a retina with visible blood vessels. The text overlay reads: "FDA warns GLP-1 drugs carry potential risk of rare eye condition. Agency requiring pharma companies to inform patients, doctors of 'eye stroke' condition.

2

1,050

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests. trib.al/RfvxUYG

Dutch antitrust regulators probe Biogen over test for its MS drug

Dutch antitrust regulators probe Biogen over test for its MS drug

Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

2

1,057

STAT retweeted

Jonathan Wosen, Ph.D.@JonathanWosen18h

Ionis Pharmaceuticals ($IONS) shares plummet after slow rollout of biotech’s triglyceride-lowering drug. My latest for @statnews statnews.com/2026/11/09/ioni…

Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug

Ionis Pharmaceuticals shares plummet after slow rollout of biotech’s triglyceride-lowering drug

Ionis Pharmaceuticals lost more than $1 billion in market value on Monday after the company slashed sales projections for a triglyceride-lowering drug.

1

942

STAT retweeted

Adam Feuerstein ✡️

@adamfeuerstein7h

PepGen $PEPG says early trial for muscular dystrophy drug looks promising statnews.com/2026/11/10/musc… via @Jasonmmast

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.

2

34

8,539

The biotech PepGen said that its experimental drug had shown, by one key measure, the most promising early data yet in the race to treat a muscle disorder that affects over 100,000 people. statnews.com/2026/11/10/musc…

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.

2

996

Three holdout states could reconsider Medicaid expansion after Democratic election victories shift power in Texas, Georgia, and Wisconsin. statnews.com/2026/11/10/medi…

State Democratic wins make Medicaid expansion a possibility for more than a million people

State Democratic wins make Medicaid expansion a possibility for more than a million people

Texas, Georgia, and Wisconsin may expand their Medicaid programs when Democrats take power.

1

1,128

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.” trib.al/YCQZ7TY

GLP-1s are given an FDA warning for rare eye condition risk

GLP-1s are given an FDA warning for rare eye condition risk

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”

1,114

GLP-1 drugs have exploded in popularity in a relatively short window of time. But as with any drugs given to large populations, side effects can show up in real-world use that weren’t observed in trials. Read more about the FDA's warning on GLP-1s here: trib.al/Vryn60B

GLP-1s are given an FDA warning for rare eye condition risk

GLP-1s are given an FDA warning for rare eye condition risk

The FDA warned that GLP-1 drugs carry a potential risk of a rare but serious eye condition sometimes referred to as an “eye stroke.”

3

4

1,399

The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of… trib.al/tgusFLO

Pharmalittle: We're reading about an approval for novel drug for strokes, a warning for GLP-1...

Pharmalittle: We're reading about an approval for novel drug for strokes, a warning for GLP-1...

The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of the day.

1

2

1,242

The strain of flu that’s spreading right now is a mutated version of the strain that fueled the 2009 swine flu pandemic. That has unique implications for young adults this flu season: trib.al/O0JymIU

Why this year’s flu season could be hitting teens and young adults hard

Why this year’s flu season could be hitting teens and young adults hard

At least 1.7 million cases of flu have been reported so far this year. Here's what experts are expecting for the rest of flu season:

4

1,326

At least 1.7 million cases of flu have been reported so far this year. Here's what experts are expecting for the rest of flu season: trib.al/rxpGjKe

Why this year’s flu season could be hitting teens and young adults hard

Why this year’s flu season could be hitting teens and young adults hard

At least 1.7 million cases of flu have been reported so far this year. Here's what experts are expecting for the rest of flu season:

2

3

1,468

PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1. trib.al/QeFX6mv

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says early trial for muscular dystrophy drug looks promising

PepGen says its candidate is correcting more of the genetic stutter found in myotonic dystrophy type 1.

3

3

1,629

BIO CEO: “Today’s biotech race is our generation’s Space Race.” trib.al/1Zcssnt

BIO CEO: American biotech needs a coordinated plan to beat China — now

BIO CEO: American biotech needs a coordinated plan to beat China — now

BIO CEO: “Today’s biotech race is our generation’s Space Race.”

1

6

3,753

Texas, Georgia, and Wisconsin may expand their Medicaid programs when Democrats take power. trib.al/Yn1Ffnp

State Democratic wins make Medicaid expansion a possibility for more than a million people

State Democratic wins make Medicaid expansion a possibility for more than a million people

Texas, Georgia, and Wisconsin may expand their Medicaid programs when Democrats take power.

1,748